DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
Open Access
- 10 October 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Hematology & Oncology
- Vol. 9 (1), 1-12
- https://doi.org/10.1186/s13045-016-0337-3
Abstract
DNMT3A mutations are frequently discovered in acute myeloid leukemia (AML), associated with poor outcome. Recently, a relapse case report of AML extramedullary disease has showed that AML cells harboring DNMT3A variation were detected in the cerebral spinal fluid. However, whether a causal relationship exists between DNMT3A mutation (D3Amut) and extramedullary infiltration (EMI) is unclear. We took advantage of DNMT3A (R882C) mutation-carrying AML cell strain, that is, OCI-AML3, assessing its migration ability in vitro and in vivo. By RNA interfering technology and a xenograft mouse model, we evaluated the effect of DNMT3A mutation on cell mobility and explored the possible mechanism. OCI-AML3 displayed extraordinary migration ability in vitro and infiltrated into meninges of NOD/SCID mice after intravenous transfusion. We found that this leukemic migration or infiltration capacity was significantly compromised by the knockdown of DNMT3A mutant. Notably, TWIST1, a critical inducer of epithelial–mesenchymal transition, which underlies the metastasis of carcinomas, was highly expressed in association with R882 mutations. Abrogation of TWIST1 in DNMT3A mutated cells considerably weakened their mobility or infiltration. Our results demonstrate that D3Amut in OCI-AML3 strain enhances leukemic aggressiveness by promoting EMI process, which is partially through upregulating TWIST1.Keywords
Funding Information
- National Natural Science Foundation of China (National Science Foundation of China) (81400106)
- Shanghai Young Doctor Training Program (2015)
- National Natural Science Foundation of China (National Science Foundation of China) (81400106)
- Chinese National Key Basic Research Project (973:2013CB966803)
- Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ201407)
This publication has 31 references indexed in Scilit:
- Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantationHuman Pathology, 2014
- Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemiaAnnals of Hematology, 2013
- Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemiaLeukemia Research, 2013
- Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2Tumor Biology, 2012
- Management of extramedullary leukemia as a presentation of acute myeloid leukemia.Journal of the National Comprehensive Cancer Network, 2012
- How I treat extramedullary acute myeloid leukemiaBlood, 2011
- Cytogenetic profile of patients with acute myeloid leukemia and central nervous system diseaseCancer, 2011
- The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cellsLeukemia Research, 2010
- Enhanced invasiveness of drug‐resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase‐2International Journal of Cancer, 2009
- Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcomeLeukemia Research, 2004